Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Siegwald

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
International Journal of MS Care|January 24, 2014
Relationship between disease-modifying therapy and depression in multiple sclerosisStephen S Kirzinger, Jason Jones, Angela Siegwald, et al.
Current Therapeutic Research, Clinical and Experimental|April 4, 2022
Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapyMary Beth Yacyshyn, James Collins, Michelle Chua, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
International Journal of MS Care|January 24, 2014
Relationship between disease-modifying therapy and depression in multiple sclerosisStephen S Kirzinger, Jason Jones, Angela Siegwald, et al.
Current Therapeutic Research, Clinical and Experimental|April 4, 2022
Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapyMary Beth Yacyshyn, James Collins, Michelle Chua, et al.
Pageof 1